Primary Site >> Stomach Cancer

Gene >> AKT3

Journal: Cancer Res. 2000 Nov 1;60(21):6201-7.
Title: Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy.
Author: Izuishi, K|Kato, K|Ogura, T|Kinoshita, T|Esumi, H
PMID: 11085546
Journal: Oncology. 2006;70(4):285-9. Epub 2006 Oct 16.
Title: Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas.
Author: Soung, Young Hwa|Lee, Jong Woo|Nam, Suk Woo|Lee, Jung Young|Yoo, Nam Jin|Lee, Sug Hyung
PMID: 17047397
Journal: Eur Rev Med Pharmacol Sci. 2017 Nov;21(22):5112-5120.
Title: MicroRNA-582-5p suppressed gastric cancer cell proliferation via targeting AKT3.
Author: Jin, Y|Tao, L-P|Yao, S-C|Huang, Q-K|Chen, Z-F|Sun, Y-J|Jin, S-Q
PMID: 29228422
Journal: Oncotarget. 2017 Oct 19;8(57):97260-97272.
Title: Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer.
Author: Ye, Rui|Wei, Bo|Li, Sheng|Liu, Wei|Liu, Juntao|Qiu, Luan|Wu, Xuan|Zhao, Zhifei|Li, Jianxiong
PMID: 29228608
Journal: J BUON. 2017 Nov-Dec;22(6):1488-1493.
Title: Study on the association between PI3K/AKT/mTOR signaling pathway gene polymorphism and susceptibility to gastric cancer.
Author: Qi, Lei|Sun, Kewen|Zhuang, Yun|Yang, Jing|Chen, Jianping
PMID: 29332342